The Evolution and Impact of ePROs in Clinical Trials
About this webinar
This webinar will examine the importance of electronic patient-reported outcomes (ePROs) and how working at pace with methodological rigour led to the development of the Symptom Burden QuestionnaireTM (SBQTM), a new ePRO measure which includes 16 symptoms scales, each measuring a different symptom. The featured speakers will also talk about the feasibility trial of non-pharmacological interventions as part of the Therapies for Long COVID (TLC) study.
To avoid increasing health disparities in clinical trials, underserved groups should be included through PRO-specific ethical guidelines for clinical research so that patient-reported outcomes are collected.
Register for this webinar to learn about the impact of ePROs through a unique ePRO measure that is tailored to individual patient needs.
Who should attend
Attendees from Biotech, Emerging Biopharma, CROs and Patient Advocacy organisations, curious about the impact of ePROs and working in:
- RWE
- Clinical Operations
- Patient Engagement
What you will learn
Attendees will gain insights into:
- The evolution of ePROs based on the work at University of Birmingham’s Centre for Patient Reported Outcome Research
- How the Symptom Burden QuestionnaireTM for Long COVID system (SBQTM-LC) was developed at pace and configured via complex pathways in the Atom5TM clinical trial platform
- The story behind which non-pharmacological interventions were designed and selected as part of the Therapies for Long COVID (TLC) feasibility study
Featured Speakers
Prof. Melanie Calvert
Melanie Calvert, PhD, Professor of Outcomes Methodology at the University of Birmingham, has extensive experience in the design and analysis of clinical trials, trials methodology, systematic reviews, meta-analysis, economic evaluation and epidemiology. Her primary research interests are outcomes research, including the use of composite outcomes and best practice for patient-reported outcome assessment in clinical trials and routine practice.
Dr. Sarah Hughes
Sarah Hughes is a Research Fellow in the Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research. Her research interests focus on the development and validation of patient-reported outcomes and their implementation within the evolving landscapes of health and social care. She has methodological expertise in qualitative and mixed-methods research, evidence syntheses and psychometrics.
Dr. Christel McMullan
Christel McMullan is a Qualitative Research Fellow in the Centre for Patient Reported Outcomes Research in the Institute of Applied Health Research. Her main interests lie in electronic patient-reported outcomes and using qualitative research to explore and understand patients’ experiences of disease and trial processes. She is currently leading/working on a range of projects around using electronic patient-reported outcomes measures (ePROMs).
Chris Frost
Chris Frost is the Chief Operations Officer at Aparito and is responsible for delivering Aparito’s objectives and the continuous evolution of their flagship product, Atom5TM. Chris has a passion for developing innovative digital outcome measures and as such has been responsible for the delivery of 1000+ eCOA tools and co-authored several papers during his time at Aparito.
Partner for this event
Aparito
Patients living with life-limiting diseases need access to clinical trials and innovative treatments.
Aparito digitizes clinical trials to provide that access, wherever patients are.
We unlock real-world data through mobile apps, video assessments & wearable devices via Atom5™, our iOS & Android-compatible web and mobile app platform.
Available in 193 countries and 125 languages, the Atom5™ platform integrates clinical & regulatory expertise to capture patient data and develop digital endpoints for hybrid and decentralized clinical trials to streamline the drug development process.
